IOC Q4 Net Profit comes at Rs1,236 Cr
IOC Q4 Net Profit comes at Rs1, 236 Cr
Total Income at Rs.80, 449.7 Cr
EBITDA at Rs.10, 044 Cr
EBITDA Margin At 5%
GRM At $3/bbl Vs $6/bbl (QoQ)
Canara Bank Q4: Net Loss at Rs3,905 Cr
Canara Bank Q4: Net Loss at Rs3, 905 Cr
Gross NPA At 9.4% Vs 5.84% (QoQ)
Gross NPA +59.7% at Rs.31, 638 Cr Vs Rs.19, 813 Cr (QoQ)
Net NPA At 6.42% Vs 3.90% (QoQ)
Tax Write-back At Rs.779.5 Cr Vs Expense of Rs.110 Cr (YoY)
Provisions at Rs.6, 331 Cr Vs Rs.1, 429 Cr (QoQ)
NII -4.5% at Rs.2, 374 Cr Vs Rs.2, 486 Cr (YoY)
SBI Q4FY16: Mixed Bag performance, Asset quality worsens
State Bank of India Q4FY16 results first cut: Mixed Bag performance
SBI Q4: Net Profit -66.2% At Rs.1,264 Cr Vs Rs.3,742 Cr (YoY)
Gross NPA +34.9% At Rs.98,172 Cr Vs Rs.72,791 Cr (QoQ)
Gross NPA At 6.5% Vs 5.1% (QoQ)
Net NPA At 3.81% Vs 2.89% (QoQ)
Net NPA +38.7% At Rs.55,807 Cr Vs Rs.40,249 Cr (QoQ)
Slippages At Rs.30,312 Cr Vs Rs.20,692 Cr (QoQ)
Provisions For NPA At Rs.12,139.2 Cr Vs Rs.7,644.6 Cr (QoQ)
Lupin gains on receiving EIR for Mandideep facility
Shares of Lupin gained 3% to Rs1507 on NSE on back of reports that the company has got Establishment Inspection Report (EIR) for its Mandideep facility.
This is sentimentally positive for Lupin; stock is up by 3%; USFDA clearance for Goa plant will be key to watch for going forward.
Torrent Pharma in talks to buy Glochem Industries for Rs300 crore
Torrent Pharma in talks to buy Glochem Industries for Rs300 crore – Long term positive for Torrent if deal goes thru
Torrent Pharma is in advanced talks to buy bulk drugs supplier Glochem Industries for about Rs300 crore.
Glochem is a medium-sized company that makes bulk drugs, or active ingredients, which are used as raw material for medicines and has USFDA approved sites in Hyderabad and Vizag where oral bulk actives are manufactured.
Read our more services below:
CapitalStars Financial Research Financial Advisory Services
No comments:
Post a Comment